Accuracy of Tuberculosis Infection Diagnosis through IP-10-Based Assays for Immune Detection of Present Mycobacterium tuberculosis: A Cross-Sectional Evaluation
Stoichita, A.; Burecu, M.; Nita, C.; Teleaga, C.; Radu, A. D.; Mihai, M.; Mahler, B.; Ibraim, E.
Show abstract
BackgroundReliable detection of latent Mycobacterium tuberculosis (Mtb) infection (LTBI) remains challenging, particularly in TB contacts and immunocompromised individuals, where interferon-{gamma} release assays (IGRAs) demonstrate variable sensitivity. IP-10, a chemokine produced at substantially higher concentrations than IFN-{gamma}, represents a promising immune marker. This study aimed to evaluate the diagnostic performance of two IP-10 based assays RIDA(R)QUICK TB (lateral flow) and RIDASCREEN(R) TB (ELISA), by comparison with QuantiFERON-TB Gold Plus (QFT-Plus) assay or a composite reference standard. MethodsA cross-sectional diagnostic accuracy study enrolled 99 adults: 49 with culture-confirmed active pulmonary TB, 30 close TB contacts and 20 individuals with autoimmune disease, in Bucharest, Romania. All participants underwent RIDA Quick, RIDA Screen and QFT-Plus testing. Indeterminate results for all assays were reclassified using a composite reference standard. ResultsAgainst culture in active TB cases, RIDA(R)QUICK TB demonstrated a sensitivity of 85.7% (95% CI: 72.8-94.1) and PPV of 97.7%, while RIDA(R)SCREEN TB achieved 91.8% sensitivity (95% CI: 80.4-97.7) and 97.8% PPV. Specificity and NPV could not be reliably estimated due to the near-absence of true-negative individuals. Agreement with QFT-Plus was moderate to good ({kappa}=0.47-0.93).ROC analysis performed against QFT-Plus as a comparator demonstrated good immunological discrimination for RIDA(R)QUICK TB (AUC = 0.828) and RIDA(R)SCREEN TB (AUC = 0.767), reflecting concordance with QFT-Plus rather than diagnostic accuracy against confirmed infection. ConclusionIP-10 based assays demonstrated higher sensitivity than QFT-Plus and excellent PPV across bacteriological standard, supporting their use as complementary tools for LTBI detection. Larger, more heterogeneous cohorts are needed to accurately define specificity and operational integration.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Acceptable Performance of the Abbott ID NOW Among Symptomatic Individuals with Confirmed COVID-19 92%
- CD36 and SR-B1 Polymorphisms Exhibit Distinct Association Patterns in Active and Latent Tuberculosis 90%
- Optimization and validation of a quadruplex real-time PCR assay for the diagnosis of diphtheria 90%
Similar papers in this journal
- Diagnostic performance of host protein signatures as a triage test for active pulmonary TB 95%
- Host blood protein biomarkers to screen for Tuberculosis disease: a systematic review and meta-analysis 95%
- Diagnostic accuracy study of a novel blood-based assay for identification of TB in people living with HIV 95%
Similar papers in this journal
- Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study 92%
- Patients with presumed tuberculosis in sub-Saharan Africa that are not diagnosed with tuberculosis: a systematic review and meta-analysis 91%
- Decline in prevalence of tuberculosis following an intensive case-finding campaign and the COVID-19 pandemic in an urban Ugandan community 89%
Similar papers in this journal
- Head-to head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UK 93%
- Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis 93%
- Prevalence and predictors of latent tuberculosis infection among people living with HIV in a high tuberculosis burden context 92%
Similar papers in this journal
- Mortality of Drug-resistant Tuberculosis in High-burden Countries: Comparison of Routine Drug Susceptibility Testing with Whole-genome Sequencing 91%
- Comparison of seven commercial SARS-CoV-2 rapid Point-of-Care Antigen tests 90%
- Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.